Human enterovirus 71 immunoglobulin (PH4)
肠道病毒71型人免疫球蛋白(PH4)
Report date: 2022/01/14 13:23:58
Base Information
Drug NameHuman enterovirus 71 immunoglobulin (PH4)
Drug Alias NameN/A
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusDiscontinued (IND)
Highest Status in ChinaDiscontinued
Originator CompaniesTonrol Bio-Pharmaceutical Co Ltd
China Registration ClassClass 1 therapeutic biologic in China
Develop Information
Active CompaniesN/A
Inactive CompaniesTonrol Bio-Pharmaceutical Co Ltd
Active IndicationsN/A
Inactive Indications
Other Information
ATC CodeN/A
Related LinksN/A